PPARα activation increases triglyceride mass and adipose differentiation-related protein in hepatocytes

Journal of Lipid Research

Volumn 47, Issue 2, 2006, Pages 329-340

  Edvardsson, Ulrika ^a,b,c   Ljungberg, Anna ^a,b   Lindén, Daniel ^a,c   William Olsson, Lena ^c   Peilot Sjögren, Helena ^c   Ahnmark, Andrea ^c   Oscarsson, Jan ^a,b,c  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

Apolipoprotein B 100; Apolipoprotein B 48; Fatty acid oxidation; Peroxisome proliferator activated receptor ; Primary hepatocytes; Triglyceride secretion; Triglyceride synthesis; Wy14,643

Indexed keywords

ADIPOPHILIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PIRINIXIC ACID; TRIACYLGLYCEROL; ACYL COENZYME A OXIDASE; ADFP PROTEIN, MOUSE; APOLIPOPROTEIN B; APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; CARNITINE PALMITOYLTRANSFERASE; LONG CHAIN ACYL COENZYME A DEHYDROGENASE; MEMBRANE PROTEIN; PALMITIC ACID; PEROXISOME PROLIFERATOR; PYRIMIDINE DERIVATIVE;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG EFFECT; FATTY ACID OXIDATION; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DRUG ANTAGONISM; FAT INTAKE; GENE EXPRESSION; GENETIC TRANSFECTION; GENETICS; LIVER; METABOLISM; MOUSE; MOUSE MUTANT; OXIDATION REDUCTION REACTION; SECRETION;

ACYL-COA DEHYDROGENASE, LONG-CHAIN; ACYL-COA OXIDASE; ANIMALS; APOLIPOPROTEIN B-100; APOLIPOPROTEIN B-48; APOLIPOPROTEINS B; CARNITINE O-PALMITOYLTRANSFERASE; DIETARY FATS; GENE EXPRESSION; HEPATOCYTES; LIVER; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OXIDATION-REDUCTION; PALMITIC ACID; PEROXISOME PROLIFERATORS; PPAR ALPHA; PYRIMIDINES; TRANSFECTION; TRIGLYCERIDES;

EID: 33244494398     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M500203-JLR200     Document Type: Article

References (66)

1. Desvergne, B., and W. Wahli. 1999. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 20: 649-688.
2. Braissant, O., F. Foufelle, C. Scotto, M. Dauça, and W. Wahli. 1996. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology. 137: 354-366.
3. Kliewer, S. A., B. M. Forman, B. Blumberg, E. S. Ong, U. Borgmeyer, D. J. Mangelsdorf, K. Umesono, and R. M. Evans. 1994. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. USA. 91: 7355-7359.
4. Mukherjee, R., L. Jow, G. E. Croston, and J. R. Paterniti, Jr. 1997. Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARgamma2 versus PPARgamma1 and activation with retinoid X receptor agonists and antagonists. J. Biol. Chem. 272: 8071-8076.
5. Auboeuf, D., J. Rieusset, L. Fajas, P. Vallier, V. Frering, J. P. Riou, B. Staels, J. Auwerx, M. Laville, and H. Vidal. 1997. Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients. Diabetes. 46: 1319-1327.
6. Sirtori, C. R., and G. Franceschini. 1988. Effects of fibrates on serum lipids and atherosclerosis. Pharmacol. Ther. 37: 167-191.
7. Diabetes Atherosclerosis Intervention Study Investigators. 2001. Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study. Lancet. 357: 905-910.
8. Schoonjans, K., J. Peinado-Onsurbe, A. M. Lefebvre, R. A. Heyman, M. Briggs, S. Deeb, B. Staels, and J. Auwerx. 1996. PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J. 15: 5336-5348.
9. Hertz, R., J. Bishara-Shieban, and J. Bar-Tana. 1995. Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III. J. Biol. Chem. 270: 13470-13475.
10. Staels, B., N. Vu-Dac, V. A. Kosykh, R. Saladin, J. C. Fruchart, J. Dallongeville, and J. Auwerx. 1995. Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates. J. Clin. Invest. 95: 705-712.
11. Caslake, M. J., C. J. Packard, A. Gaw, E. Murray, B. A. Griffin, B. D. Vallance, and J. Shepherd. 1993. Fenofibrate and LDL metabolic heterogeneity in hypercholesterolemia. Arterioscler. Thromb. 13: 702-711.
12. Guerin, M., W. Le Goff, E. Frisdal, S. Schneider, D. Milosavljevic, E. Bruckert, and M. J. Chapman. 2003. Action of ciprofibrate in type IIb hyperlipoproteinemia: modulation of the atherogenic lipoprotein phenotype and stimulation of high-density lipoprotein-mediated cellular cholesterol efflux. J. Clin. Endocrinol. Metab. 88: 3738-3746.
13. Packard, C. J. 2003. Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein. Biochem. Soc. Trans. 31: 1066-1069.
14. Kesäniemi, Y. A., and S. M. Grundy. 1984. Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man. J. Am. Med. Assoc. 251: 2241-2246.
15. Petit, D., M. T. Bonnefis, C. Rey, and R. Infante. 1988. Effects of ciprofibrate and fenofibrate on liver lipids and lipoprotein synthesis in normo- and hyperlipidemic rats. Atherosclerosis. 74: 215-225.
16. Lindén, D., K. Lindberg, J. Oscarsson, C. Claesson, L. Asp, L. Li, M. Gustafsson, J. Borén, and S. O. Olofsson. 2002. Influence of peroxisome proliferator-activated receptor alpha agonists on the intracellular turnover and secretion of apolipoprotein (Apo) B-100 and ApoB-48. J. Biol. Chem. 277: 23044-23053.
17. Lamb, R. G., J. C. Koch, and S. R. Bush. 1993. An enzymatic explanation of the differential effects of oleate and gemfibrozil on cultured hepatocyte triacylglycerol and phosphatidylcholine biosynthesis and secretion. Biochim. Biophys. Acta. 1165: 299-305.
18. Waterman, I. J., and V. A. Zammit. 2002. Differential effects of fenofibrate or simvastatin treatment of rats on hepatic microsomal overt and latent diacylglycerol acyltransferase activities. Diabetes. 51: 1708-1713.
19. Londos, C., D. L. Brasaemle, C. J. Schultz, J. P. Segrest, and A. R. Kimmel. 1999. Perilipins, ADRP, and other proteins that associate with intracellular neutral lipid droplets in animal cells. Semin. Cell Dev. Biol. 10: 51-58.
20. Jiang, H. P., and G. Serrero. 1992. Isolation and characterization of a full-length cDNA coding for an adipose differentiation-related protein. Proc. Natl. Acad. Sci. USA. 89: 7856-7860.
21. Brasaemle, D. L., T. Barber, N. E. Wolins, G. Serrero, E. J. Blanchette-Mackie, and C. Londos. 1997. Adipose differentiation-related protein is an ubiquitously expressed lipid storage droplet-associated protein. J. Lipid Res. 38: 2249-2263.
22. Heid, H. W., R. Moll, I. Schwetlick, H. R. Rackwitz, and T. W. Keenan. 1998. Adipophilin is a specific marker of lipid accumulation in diverse cell types and diseases. Cell Tissue Res. 294: 309-321.
23. Steiner, S., D. Wahl, B. L. K. Mangold, R. Robison, J. Raymackers, L. Meheus, N. L. Anderson, and A. Cordier. 1996. Induction of the adipose differentiation-related protein in liver of etomoxir-treated rats. Biochem. Biophys. Res. Commun. 218: 777-782.
24. Imamura, M., T. Inoguchi, S. Ikuyama, S. Taniguchi, K. Kobayashi, N. Nakashima, and H. Nawata. 2002. ADRP stimulates lipid accumulation and lipid droplet formation in murine fibroblasts. Am. J. Physiol. Endocrinol. Metab. 283: E775-E783.
25. Larigauderie, G., C. Furman, M. Jaye, C. Lasselin, C. Copin, J. C. Fruchart, G. Castro, and M. Rouis. 2004. Adipophilin enhances lipid accumulation and prevents lipid efflux from THP-1 macrophages: potential role in atherogenesis. Arterioscler. Thromb. Vasc. Biol. 24: 504-510.
26. Gao, J., and G. Serrero. 1999. Adipose differentiation related protein (ADRP) expressed in transfected COS-7 cells selectively stimulates long chain fatty acid uptake. J. Biol. Chem. 274: 16825-16830.
27. Gao, J., H. Ye, and G. Serrero. 2000. Stimulation of adipose differentiation related protein (ADRP) expression in adipocyte precursors by long-chain fatty acids. J. Cell. Physiol. 182: 297-302.
28. Vosper, H., L. Patel, T. L. Graham, G. A. Khoudoli, A. Hill, C. H. Macphee, I. Pinto, S. A. Smith, K. E. Suckling, C. R. Wolf, et al. 2001. The peroxisome proliferator-activated receptor delta promotes lipid accumulation in human macrophages. J. Biol. Chem. 276: 44258-44265.
29. Hodgkinson, C. P., and S. Ye. 2003. Microarray analysis of peroxisome proliferator-activated receptor-gamma induced changes in gene expression in macrophages. Biochem. Biophys. Res. Commun. 308: 505-510.
30. Gupta, R. A., J. A. Brockman, P. Sarraf, T. M. Willson, and R. N. DuBois. 2001. Target genes of peroxisome proliferator-activated receptor gamma in colorectal cancer cells. J. Biol. Chem. 276: 29681-29687.
31. Chawla, A., C. H. Lee, Y. Barak, W. He, J. Rosenfeld, D. Liao, J. Han, H. Kang, and R. M. Evans. 2003. PPARdelta is a very low-density lipoprotein sensor in macrophages. Proc. Natl. Acad. Sci. USA. 100: 1268-1273.
32. Targett-Adams, P., M. J. McElwee, E. Ehrenborg, M. C. Gustafsson, C. N. Palmer, and J. McLauchlan. 2005. A PPAR response element regulates transcription of the gene for human adipose differentiation-related protein. Biochim. Biophys. Acta. 1728: 95-104.
33. Ljung, B., K. Bamberg, B. Dahllöf, A. Kjellstedt, N. D. Oakes, J. Östling, L. Svensson, and G. Camejo. 2002. AZ 242, a novel PPARalpha/gamma agonist with beneficial effects on insulin resistance and carbohydrate and lipid metabolism in ob/ob mice and obese Zucker rats. J. Lipid Res. 43: 1855-1863.
34. Lee, S. S., T. Pineau, J. Drago, E. J. Lee, J. W. Owens, D. L. Kroetz, P. M. Fernandez-Salguero, H. Westphal, and F. J. Gonzalez. 1995. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol. 15: 3012-3022.
35. Lindén, D., L. William-Olsson, M. Rhedin, A. K. Asztely, J. C. Clapham, and S. Schreyer. 2004. Overexpression of mitochondrial GPAT in rat hepatocytes leads to decreased fatty acid oxidation and increased glycerolipid biosynthesis. J. Lipid Res. 45: 1279-1288.
36. Zhang, W. W., P. E. Koch, and J. A. Roth. 1995. Detection of wild-type contamination in a recombinant adenoviral preparation by PCR. Biotechniques. 18: 444-447.
37. Carlsson, L., I. Nilsson, and J. Oscarsson. 1998. Hormonal regulation of liver fatty acid-binding protein in vivo and in vitro: effects of growth hormone and insulin. Endocrinology. 139: 2699-2709.
38. Lindén, D., M. Alsterholm, H. Wennbo, and J. Oscarsson. 2001. PPARalpha deficiency increases secretion and serum levels of apolipoprotein B-containing lipoproteins. J. Lipid Res. 42: 1831-1840.
39. Améen, C., and J. Oscarsson. 2003. Sex difference in hepatic microsomal triglyceride transfer protein expression is determined by the growth hormone secretory pattern in the rat. Endocrinology. 144: 3914-3921.
40. Leung, K. C., and K. K. Ho. 1997. Stimulation of mitochondrial fatty acid oxidation by growth hormone in human fibroblasts. J. Clin. Endocrinol. Metab. 82: 4208-4213.
41. Labarca, C., and K. Paigen. 1980. A simple, rapid, and sensitive DNA assay procedure. Anal. Biochem. 102: 344-352.
42. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Med. Sci. 37: 911-917.
43. Sjöberg, A., J. Oscarsson, K. Boström, T. L. Innerarity, S. Edén, and S. O. Olofsson. 1992. Effects of growth hormone on apolipoprotein-B (apoB) messenger ribonucleic acid editing, and apoB 48 and apoB 100 synthesis and secretion in the rat liver. Endocrinology. 130: 3356-3364.
44. Lindén, D., A. Sjöberg, L. Asp, L. Carlsson, and J. Oscarsson. 2000. Direct effects of growth hormone on production and secretion of apolipoprotein B from rat hepatocytes. Am. J. Physiol. Endocrinol. Metab. 279: E1335-E1346.
45. Murphy, E. J., T. A. Rosenberger, and L. A. Horrocks. 1996. Separation of neutral lipids by high-performance liquid chromatography: quantification by ultraviolet, light scattering and fluorescence detection. J. Chromatogr. B Biomed. Appl. 685: 9-14.
46. Folch, J., M. Lees, and G. H. Sloane Stanley. 1957. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226: 497-509.
47. Tugwood, J. D., I. Issemann, R. G. Anderson, K. R. Bundell, W. L. McPheat, and S. Green. 1992. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J. 11: 433-439.
48. Améen, C., U. Edvardsson, A. Ljungberg, L. Asp, P. Åkerblad, A. Tuneld, S. O. Olofsson, D. Lindén, and J. Oscarsson. 2005. Activation of peroxisome proliferator-activated receptor alpha increases the expression and activity of microsomal triglyceride transfer protein in the liver. J. Biol. Chem. 280: 1224-1229.
49. Liu, P. C., R. Huber, M. D. Stow, K. L. Schlingmann, P. Collier, B. Liao, J. Link, T. C. Burn, G. Hollis, P. R. Young, et al. 2003. Induction of endogenous genes by peroxisome proliferator activated receptor alpha ligands in a human kidney cell line and in vivo. J. Steroid Biochem. Mol. Biol. 85: 71-79.
50. Hertz, R., J. Arnon, and J. Bar-Tana. 1985. The effect of bezafibrate and long-chain fatty acids on peroxisomal activities in cultured rat hepatocytes. Biochim. Biophys. Acta. 836: 192-200.
51. Chou, C. J., M. Haluzik, C. Gregory, K. R. Dietz, C. Vinson, O. Gavrilova, and M. L. Reitman. 2002. WY14,643, a peroxisome proliferator- activated receptor alpha (PPARalpha) agonist, improves hepatic and muscle steatosis and reverses insulin resistance in lipoatrophic A-ZIP/F-1 mice. J. Biol. Chem. 277: 24484-24489.
52. Ip, E., G. C. Farrell, G. Robertson, P. Hall, R. Kirsch, and I. Leclercq. 2003. Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice. Hepatology. 38: 123-132.
53. Miller, D. B., and J. D. Spence. 1998. Clinical pharmacokinetics of fibric acid derivatives (fibrates). Clin. Pharmacokinet. 34: 155-162.
54. Chung, S., J. M. Brown, M. B. Sandberg, and M. McIntosh. 2005. Trans-10,cis-12 CLA increases adipocyte lipolysis and alters lipid droplet-associated proteins: role of mTOR and ERK signaling. J. Lipid Res. 46: 885-895.
55. Xu, G., C. Sztalryd, X. Lu, J. T. Tansey, J. Gan, H. Dorward, A. R. Kimmel, and C. Londos. Post-translational regulation of ADRP by the ubiquitin/proteosome pathway. J. Biol. Chem. Epub ahead of print. August 22, 2005, doi:10.1074/jbc.M506569200.
56. Martin, G., K. Schoonjans, A. M. Lefebvre, B. Staels, and J. Auwerx. 1997. Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARalpha and PPARgamma activators. J. Biol. Chem. 272: 28210-28217.
57. Issemann, I., R. Prince, J. Tugwood, and S. Green. 1992. A role for fatty acids and liver fatty acid binding protein in peroxisome proliferation? Biochem. Soc. Trans. 20: 824-827.
58. Storch, J., and A. E. Thumser. 2000. The fatty acid transport functionof fatty acid-binding proteins. Biochim. Biophys. Acta. 1486: 28-44.
59. Jamil, H., J. K. Dickson, Jr., C. H. Chu, M. W. Lago, J. K. Rinehart, S. A. Biller, R. E. Gregg, and J. R. Wetterau. 1995. Microsomal triglyceride transfer protein. Specificity of lipid binding and transport. J. Biol. Chem. 270: 6549-6554.
60. Liao, W., K. Kobayashi, and L. Chan. 1999. Adenovirus-mediated overexpression of microsomal triglyceride transfer protein (MTP): mechanistic studies on the role of MTP in apolipoprotein B-100 biogenesis. Biochemistry. 38: 7532-7544.
61. Tietge, U. J., A. Bakillah, C. Maugeais, K. Tsukamoto, M. Hussain, and D. J. Rader. 1999. Hepatic overexpression of microsomal triglyceride transfer protein (MTP) results in increased in vivo secretion of VLDL triglycerides and apolipoprotein B. J. Lipid Res. 40: 2134-2139.
62. Raabe, M., L. M. Flynn, C. H. Zlot, J. S. Wong, M. M. Veniant, R. L. Hamilton, and S. G. Young. 1998. Knockout of the abetalipoproteinemia gene in mice: reduced lipoprotein secretion in heterozygotes and embryonic lethality in homozygotes. Proc. Natl. Acad. Sci. USA. 95: 8686-8691.
63. Fu, T., D. Mukhopadhyay, N. O. Davidson, and J. Borensztajn. 2004. The peroxisome proliferator-activated receptor alpha (PPARalpha) agonist ciprofibrate inhibits apolipoprotein B mRNA editing in low density lipoprotein receptor-deficient mice: effects on plasma lipoproteins and the development of atherosclerotic lesions. J. Biol. Chem. 279: 28662-28669.
64. Gibbons, G. F., D. Wiggins, A. M. Brown, and A. M. Hebbachi. 2004. Synthesis and function of hepatic very-low-density lipoprotein. Biochem. Soc. Trans. 32: 59-64.
65. Dolinsky, V. W., D. Gilham, M. Alam, D. E. Vance, and R. Lehner. 2004. Triacylglycerol hydrolase: role in intracellular lipid metabolism. Cell. Mol. Life Sci. 61: 1633-1651.
66. Dolinsky, V. W., D. Gilham, G. M. Hatch, L. B. Agellon, R. Lehner, and D. E. Vance. 2003. Regulation of triacylglycerol hydrolase expression by dietary fatty acids and peroxisomal proliferator-activated receptors. Biochim. Biophys. Acta. 1635: 20-28.